liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Innate immune receptor NOD2 promotes vascular inflammation and formation of lipid-rich necrotic cores in hypercholesterolemic mice
Karolinska Institute, Sweden; University of Gothenburg, Sweden.
Karolinska Institute, Sweden; Peking University, Peoples R China.
Karolinska Institute, Sweden; Karolinska Institute, Sweden.
Karolinska Institute, Sweden.
Show others and affiliations
2014 (English)In: European Journal of Immunology, ISSN 0014-2980, E-ISSN 1521-4141, Vol. 44, no 10, 3081-3092 p.Article in journal (Refereed) Published
Abstract [en]

Atherosclerosis is an inflammatory disease associated with the activation of innate immune TLRs and nucleotide-binding oligomerization domain-containing protein (NOD)like receptor pathways. However, the function of most innate immune receptors in atherosclerosis remains unclear. Here, we show that NOD2 is a crucial innate immune receptor influencing vascular inflammation and atherosclerosis severity. 10-week stimulation with muramyl dipeptide (MDP), the NOD2 cognate ligand, aggravated atherosclerosis, as indicated by the augmented lesion burden, increased vascular inflammation and enlarged lipid-rich necrotic cores in Ldlr(-/-) mice. Myeloid-specific ablation of NOD2, but not its downstream kinase, receptor-interacting serine/threonine-protein kinase 2, restrained the expansion of the lipid-rich necrotic core in Ldlr(-/-) chimeric mice. In vitro stimulation of macrophages with MDP enhanced the uptake of oxidized low-density lipoprotein and impaired cholesterol efflux in concordance with upregulation of scavenger receptor A1/2 and downregulation of ATP-binding cassette transporter A1. Ex vivo stimulation of human carotid plaques with MDP led to increased activation of inflammatory signaling pathways p38 MAPK and NF-kappa B-mediated release of proinflammatory cytokines. Altogether, this study suggests that NOD2 contributes to the expansion of the lipid-rich necrotic core and promotes vascular inflammation in atherosclerosis.

Place, publisher, year, edition, pages
Wiley-VCH Verlag , 2014. Vol. 44, no 10, 3081-3092 p.
Keyword [en]
Atherosclerosis; Inflammation; Innate immunity; Nucleotide-binding oligomerization domain-containing protein 2; Pattern recognition receptor
National Category
Clinical Medicine
URN: urn:nbn:se:liu:diva-112483DOI: 10.1002/eji.201444755ISI: 000343827600024PubMedID: 25042478OAI: diva2:766738

Funding Agencies|Swedish Research Council; Swedish Heart-Lung Foundation; European Union projects (Immunath, AtheroRemo, AtheroFlux); O. E. och Edla Johanssons vetenskapliga stiftelse; KI foundation; KI Joint funding postdoc position; Swedish Society for Medical Research; Chinese Scholarship Council; Peking University Health Science Center; National Health and Medical Research Council of Australia

Available from: 2014-11-28 Created: 2014-11-28 Last updated: 2014-11-28

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Li, WeiYuan, Ximing
By organisation
Division of Clinical SciencesFaculty of Health SciencesDivision of Cell Biology
In the same journal
European Journal of Immunology
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 80 hits
ReferencesLink to record
Permanent link

Direct link